Status:
RECRUITING
Glucose Monitoring After Acute Myocardial Infarct in People With Diabetes
Lead Sponsor:
Imperial College London
Conditions:
Type 2 Diabetes
Acute Myocardial Infarction
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Glucose monitoring after Acute Myocardial infarct in people with diabetes is a Dexcom funded study that is investigating whether the use of continuous glucose monitors (Dexcom ONE model) in people wit...
Detailed Description
The study 1. Patients recruited from cardiology services after ACS (n=140 participants) Following informed consent study participants with known diabetes who have had an acute myocardial infarct ...
Eligibility Criteria
Inclusion
- From the Hammersmith Hospital In-patient Cardiology Services:
- Adults aged \>18 years
- Known or newly diagnosed type 2 diabetes
- Taking one or more oral hypoglycaemic agent, GLP1 receptor analogue and/or insulin
- Admitted to Hammersmith Hospital cardiology inpatient services with ACS
- Raised blood troponin level on admission
- From Imperial College Healthcare Trust Diabetes and Cardiology Clinics:
- Adults aged \>18 years
- Known type 2 diabetes
- Previous acute coronary syndrome within the last 10 years but \> 6 months ago
- Taking one or more oral hypoglycaemic agent and /or GLP1 receptor analogue, and/or insulin
Exclusion
- From the Hammersmith Hospital In-patient Cardiology Services:
- HbA1c \<48mmol/mol
- People who have previously had bariatric surgery
- People taking hydroxyurea
- People who undergo haemodialysis or peritoneal dialysis
- Unable to participate due to other factors, as assessed by the Chief Investigators
- Pregnancy as determined by clinical team
- Known to have a terminal condition or conditions that suggest a life expectancy less than 1 year
- From Imperial College Healthcare Trust Diabetes and Cardiology Clinics:
- HbA1c \<48mmol/mol
- People who have previously had bariatric surgery
- People taking hydroxyurea
- People who undergo haemodialysis or peritoneal dialysis
- Unable to participate due to other factors, as assessed by the Chief Investigators
- Pregnancy as determined by clinical team
- Known to have a terminal condition or conditions that suggest a life expectancy less than 1 year
- Previous acute coronary syndrome more than 10 years ago or within the last 6 months
- Withdrawal criteria
- The subject has a serious event related to the study
- Investigated initiated discontinuation of study due to participation or equipment concerns
- Withdrawal of consent
Key Trial Info
Start Date :
February 7 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 1 2025
Estimated Enrollment :
160 Patients enrolled
Trial Details
Trial ID
NCT05431296
Start Date
February 7 2023
End Date
February 1 2025
Last Update
July 3 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hammersmith Hospital inpatient cardiology services
London, United Kingdom